Atlas Trials

Bispecific Antibody

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bispecific Antibody

RecordFirmDate
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT07231250)Li Zhiming2026-01-15
Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial) (NCT07309497)University of Zurich2025-12-12
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC (NCT07086326)Yang Fan, MD2025-07-31
Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study (NCT06946836)Shanghai Pulmonary Hospital, Shanghai, China2025-04-21
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. (NCT05228470)Pfizer2021-12-21

Track Bispecific Antibody automatically

Every clearance here is in the API, with alerts when new ones post.